beta
ORPN
Bioblast Pharma Ltd.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Bioblast Pharma Ltd is a clinical stage biotechnology company. It is engaged in the identification, licensing, acquisition, development and commercialization of drugs for rare and ultra-rare genetic and metabolic diseases.
Market Cap: 10.6 Million
Primary Exchange: NASDAQ Capital Market
Website: https://bioblastpharma.com
Shares Outstanding: 3.34 Million
Float: 3.34 Million
Dividend: 0.0 (0.0%)
Beta: 0.650187
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 1269 trading days
From: 2014-08-27 To: 2019-03-25
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-09-25 | 5.0 | 1.0 | 5.0 |